. "10.1002/ijc.33225" . "Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first\u2010line treatment in patients with metastatic pancreatic adenocarcinoma ( GATE 1)" . . "Assenat Eric, Mineur Laurent, Mollevi Caroline, Lopez-Crapez Evelyne, Lombard-Bohas Catherine, Samalin Emmanuelle, Portales Fabienne, Walter Thomas, de Forges H\u00E9l\u00E8ne, Dupuy Marie, Boissi\u00E8re-Michot Florence, Ho-Pun-Cheung Alexandre, Ychou Marc, Mazard Thibaut. Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first\u2010line treatment in patients with metastatic pancreatic adenocarcinoma ( GATE 1). International Journal of Cancer, 2021, 148 (3), pp.682-691. ⟨10.1002/ijc.33225⟩" . . . . . . . . "2021" .